Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.

  • Larry Moreland
  • Published 2001 in The Israel Medical Association journal : IMAJ

Abstract

There is accumulating evidence that tumor necrosis factor plays a major role in the pathogenesis of rheumatoid arthritis. Recent biotechnological advances have allowed for the development of agents that directly target TNF, a proinflammatory cytokine. In the last 2 years, the U.S. Food and Drug Administration and the European Union's Commission of the… (More)

Topics

Cite this paper

@article{Moreland2001TumorNF, title={Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.}, author={Larry Moreland}, journal={The Israel Medical Association journal : IMAJ}, year={2001}, volume={3 9}, pages={686-90} }